Cambridge Heart Ups Marketing In Anticipation Of MTWA National Coverage
This article was originally published in The Gray Sheet
Executive Summary
Anticipating a positive national coverage decision from CMS by March 21, Cambridge Heart is aggressively targeting private payors with its HeartWave II Microvolt T-Wave Alternans (MTWA) test